Moody Aldrich Partners LLC Edgewise Therapeutics, Inc. Transaction History
Moody Aldrich Partners LLC
- $475 Million
- Q4 2024
A detailed history of Moody Aldrich Partners LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 187,932 shares of EWTX stock, worth $5.32 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
187,932
Previous 151,157
24.33%
Holding current value
$5.32 Million
Previous $4.03 Million
24.37%
% of portfolio
1.06%
Previous 0.8%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
189Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$425 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$252 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$170 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$165 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$157 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.79B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...